Immucell Corp
ICCCNasdaqCIK 811641HealthcareFiscal year ends Dec 31
Reports and events: 337 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-09-1713:49 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001744329-24-000005 |
| 2024-08-2716:32 ET | SC 13D | Ownership report, active investor | 0001193125-24-207799 |
| 2024-08-1316:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001213900-24-068245 |
| 2024-08-1316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-068243 |
| 2024-07-0916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-060121 |
| 2024-06-1413:38 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-24-052776 |
| 2024-06-1411:33 ET | 8-K | 5.07 Shareholder vote results | 0001213900-24-052706 |
| 2024-06-0607:49 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-050197 |
| 2024-05-2216:50 ET | SCHEDULE 13D | Ownership report, active investor | 0001744329-24-000003 |
| 2024-05-1416:06 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001213900-24-042925 |
| 2024-05-1416:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-042926 |
| 2024-04-2609:00 ET | DEF 14A | Proxy statementPeriod 2024-06-13 | 0001213900-24-036378 |
| 2024-04-0917:19 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-031647 |
| 2024-04-0916:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-031589 |
| 2024-04-0116:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001213900-24-028718 |
| 2024-03-0613:55 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-24-020389 |
| 2024-02-2716:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-24-017522 |
| 2024-02-2716:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-017520 |
| 2024-01-0816:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-24-001894 |
| 2023-11-1615:22 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-23-087893 |
| 2023-11-1316:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001213900-23-086092 |
| 2023-11-1316:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-086101 |
| 2023-10-0516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001013762-23-002136 |
| 2023-08-1016:06 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001213900-23-065595 |
| 2023-08-1016:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-065597 |
| 2023-07-2109:04 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-23-058672 |
| 2023-07-1116:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-056198 |
| 2023-06-2913:02 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-23-052780 |
| 2023-06-2116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-23-050488 |
| 2023-05-1116:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-038528 |
| 2023-05-1116:05 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001213900-23-038529 |
| 2023-04-2810:13 ET | DEF 14A | Proxy statementPeriod 2023-06-15 | 0001213900-23-033559 |
| 2023-04-0516:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-027540 |
| 2023-03-2916:05 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001213900-23-024080 |
| 2023-02-2809:24 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-23-015065 |
| 2023-02-2116:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-013281 |
| 2023-02-0117:25 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001213900-23-006754 |
| 2023-01-0916:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-23-001673 |
| 2022-11-2116:58 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-074266 |
| 2022-11-2116:06 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001213900-22-074215 |
| 2022-11-2109:49 ET | 10-Q/A | Quarterly report, amendedPeriod 2022-06-30 | 0001213900-22-074052 |
| 2022-11-2109:44 ET | 10-Q/A | Quarterly report, amendedPeriod 2022-03-31 | 0001213900-22-074049 |
| 2022-11-1016:24 ET | 8-K | 2.02 Results of operations; 4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits | 0001213900-22-071209 |
| 2022-10-0506:35 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-062089 |
| 2022-08-1716:37 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001213900-22-049025 |
| 2022-08-1116:07 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001213900-22-046861 |
| 2022-08-1116:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-046860 |
| 2022-07-2820:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-22-042127 |
| 2022-07-0718:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001213900-22-037699 |
| 2022-06-2106:14 ET | 8-K/A | 5.07 Shareholder vote results | 0001213900-22-033723 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:08 ET. Listed shows no prices and gives no investment advice.